Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Chemistry
Class Information
Number: 530/389.2
Name: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof > Proteins, i.e., more than 100 amino acid residues > Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. > Globulins > Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed > Polyclonal antibody or immunogloblin of identified binding specificity > Binds hormone, lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, glucagon, cardiodilatin, interleukin, interferon, norepinephrine, epinephrine, acetylcholine, etc.)
Description: Subject matter involving a polyclonal antibody or immunoglobulin or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a hormone, lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter.










Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12

Patent Number Title Of Patent Date Issued
8691585 Methods for predicting pregnancy outcome in a subject by hCG assay Apr. 8, 2014
8679487 Anti-interleukin-4 receptor antibodies Mar. 25, 2014
8679489 Inhibiting cell migration Mar. 25, 2014
8673310 Stable and soluble antibodies inhibiting TNF.alpha. Mar. 18, 2014
8664366 Fusion proteins forming trimers Mar. 4, 2014
8658771 Humanized antibodies against human interferon-alpha Feb. 25, 2014
8642035 Anti-TrkB antibodies Feb. 4, 2014
8628777 Antibodies binding IL-1 related polypeptides Jan. 14, 2014
8603972 Extended GLP-1 compounds Dec. 10, 2013
8597646 Methods and compositons featuring TGF-beta antagonists for the treatment of marfan syndrome and associated disorders Dec. 3, 2013
8591901 Antibodies to TGF-.beta. Nov. 26, 2013
8580260 Method of using anti-IL-13 antibodies Nov. 12, 2013
8569462 Antibodies specific for TGF-beta and methods for treating thereof Oct. 29, 2013
8545849 Stable and soluble antibodies Oct. 1, 2013
8540988 Antibodies that bind polypeptides involved in the process of bone remodeling Sep. 24, 2013
8536311 Inhibitor protein of the wnt signal pathway Sep. 17, 2013
8524866 Antibodies to the alpha-7 nicotinic receptors and methods of treating inflammatory disorders with the same Sep. 3, 2013
8487081 Antibodies specific for human hepcidin Jul. 16, 2013
8461309 Inhibitor protein of the wnt signal pathway Jun. 11, 2013
8435525 FGF modulation of in vivo antibody production and humoral immunity May. 7, 2013
8415460 Methods of making antibodies specific for cysteine-rich soluble protein C23 Apr. 9, 2013
8415459 Antibody to GDF8 and uses thereof Apr. 9, 2013
8409579 Humanized anti-FGF19 antagonists and methods using same Apr. 2, 2013
8398966 IL-1 binding proteins Mar. 19, 2013
8398995 Method of inducing immune tolerance to type I diabetes Mar. 19, 2013
8394930 Growth factor isoform Mar. 12, 2013
8388956 Interleukin-1 alpha antibodies and methods of use Mar. 5, 2013
8388969 Interleukin-1 alpha antibodies and methods of use Mar. 5, 2013
8362216 Method of detection using antibodies that specifically bind hedgehog-derived polypeptides Jan. 29, 2013
8337850 4-1BB binding molecules Dec. 25, 2012
8333963 Method of inhibiting osteoclast activity Dec. 18, 2012
8318667 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Nov. 27, 2012
8318906 EMP2 antibodies and their therapeutic uses Nov. 27, 2012
8283131 Methods and kits for the rapid determination of patients at high risk of death during severe sepsis and septic shock Oct. 9, 2012
8278067 Method for inhibiting hyperpigmentation Oct. 2, 2012
8257708 Antibodies against cancer antigen TMEFF2 and uses thereof Sep. 4, 2012
8257704 Anti-sclerostin antibodies Sep. 4, 2012
8246953 Compositions and methods for use for antibodies against sclerostin Aug. 21, 2012
8231874 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases Jul. 31, 2012
8221748 Compositions and methods for the systemic treatment of arthritis Jul. 17, 2012
8216571 Fully human anti-VEGF antibodies and methods of using Jul. 10, 2012
RE43497 Anti-MIF antibodies Jun. 26, 2012
8193319 Antibodies to IL-17A Jun. 5, 2012
8193321 Multispecific antibodies Jun. 5, 2012
8192736 Remedy for endometriosis Jun. 5, 2012
8187603 Antibodies to human IL-22 May. 29, 2012
8182817 Antibodies to human IL-22 May. 22, 2012
8168183 Antibodies to granulocyte-macrophage colony-stimulating factor May. 1, 2012
8163884 Interleukin-21 receptor binding proteins Apr. 24, 2012
8163885 Humanized antibodies against human interferon-alpha Apr. 24, 2012

1 2 3 4 5 6 7 8 9 10 11 12










 
 
  Recently Added Patents
Coating composition, and a process for producing the same
Traffic signal mapping and detection
Vending machine
Portion of a display panel with an ambiguous facial expression icon
Owner-brokered knowledge sharing machine
Method and device for determining a set of frequencies that can be used for transmitting information between radio transceivers of a network operating with frequency hopping
Switching device and electronic apparatus using the same
  Randomly Featured Patents
Training device
System for monitoring a transient fluid
Arrangement for producing a spun thread from a staple fiber strand
Technique for repelling carriers in optical communications to minimize mutual interference
Three-finned point attack mining bit
Ultracompact Q-switched microlasers and related method
Oil hub cover for truck wheels
Valve drive mechanism for DOHC engine
Process for manufacturing a moulding plunger for hollow glass objects
Method of and device for determination of characteristic values of an internal combustion engine